Product Information
POTASSIUM CL ER 10 MEQ TABLET is a generic product labeled by Advagen Pharma Ltd., priced at $0.0828 per EA under NDC 72888007500. Its NADAC has been published 170 times since Jul 5, 2023.
FDA first approved this application on Jul 25, 2022. Its Orange Book therapeutic-equivalence code is AB3 — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Strength
750 mg/1
Manufacturer
Advagen Pharma Ltd.NDC
72888007500
Classification
Generic
Dosage Form
TABLET, FILM COATED, EXTENDED RELEASE
Route
ORAL
Effective Date
9/23/2026
Active Ingredients
POTASSIUM CHLORIDEApproval Type
Generic (ANDA)
FDA Application
ANDA215725FDA Approved
7/25/2022
TE Code
AB3
On Market Since
7/25/2022
Pharmacological Classes
Price Statistics
The NADAC for POTASSIUM CL ER 10 MEQ TABLET has been published 170 times since Jul 5, 2023, and over the history we have for it it has declined 42.9%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.0828 per EA |
|---|---|
| All-time high | $0.1451 (Jul 12, 2023) |
| All-time low | $0.0828 (Sep 23, 2026) |
| 52-week high | $0.0943 |
| 52-week low | $0.0828 |
| Median price | $0.0967 |
| Average price | $0.1023 |
| Largest weekly change | +35.0% (Aug 21, 2024) |
| Weeks tracked | 170 |
| Tracking since | Jul 5, 2023 |
Generic Alternatives
The matcher finds 10 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Advagen Pharma Ltd. manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
Potassium Chloride market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
Osmotic Laxative class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of POTASSIUM CL ER 10 MEQ TABLET?
The current National Average Drug Acquisition Cost (NADAC) for POTASSIUM CL ER 10 MEQ TABLET, manufactured by Advagen Pharma Ltd., is $0.0828 per EA (NDC 72888007500), effective Sep 30, 2026.
How has the price of POTASSIUM CL ER 10 MEQ TABLET changed over time?
Over the history we have for it, the NADAC for POTASSIUM CL ER 10 MEQ TABLET has declined 42.9%. It has been tracked across 170 weekly CMS publications since Jul 5, 2023.
What are the highest and lowest recorded NADAC prices for POTASSIUM CL ER 10 MEQ TABLET?
Since Jul 5, 2023, the NADAC for POTASSIUM CL ER 10 MEQ TABLET has ranged from a low of $0.0828 (Sep 23, 2026) to a high of $0.1451 (Jul 12, 2023), with a median of $0.0967 per EA.
Are there cheaper alternatives to POTASSIUM CL ER 10 MEQ TABLET?
10 manufacturers publish a NADAC-priced product with the same active ingredient and strength as POTASSIUM CL ER 10 MEQ TABLET in a comparable dosage form, but none are currently priced below it.
Who manufactures POTASSIUM CL ER 10 MEQ TABLET?
POTASSIUM CL ER 10 MEQ TABLET (NDC 72888007500) is labeled by Advagen Pharma Ltd., and CMS classifies it as a generic product.